Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis

Biochemical and Biophysical Research Communications

Volumn 294, Issue 2, 2002, Pages 441-447

  Fujita, Mamoru ^a,b   Hayashi, Izumi ^a,b   Yamashina, Shohei ^a   Itoman, Moritoshi ^b   Majima, Masataka ^a,b  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

ACE inhibitor; Angiogenesis; Angiotensin II; AT1a receptor; Lisinopril; Metastasis; TCV 116

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN HEXETIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PREVENTION; CONTROLLED STUDY; DRUG EFFECT; FIBROSARCOMA; IMMUNOREACTIVITY; LUNG METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA CELL; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTINEOPLASTIC AGENTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; CARCINOMA, LEWIS LUNG; CELL DIVISION; DRUG SCREENING ASSAYS, ANTITUMOR; FIBROSARCOMA; IMMUNOHISTOCHEMISTRY; LISINOPRIL; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED ICR; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; SARCOMA 180; SARCOMA, EXPERIMENTAL; SIGNAL TRANSDUCTION; TETRAZOLES;

MURINAE;

EID: 0036290279     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00496-5     Document Type: Article

References (34)

1. What is the evidence that tumors are angiogenesis dependent?
2. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
3. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
4. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting
5. Anti-angiogenesis: New concept for therapy of solid tumors
6. Tumor angiogenesis
7. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. clowes memorial award lecture
8. Angiogenesis in cancer, vascular, rheumatoid and other disease
9. The biology of vascular endothelial growth factor
10. Angiotensin II receptors and angitensin II receptor antagonists
11. International union of pharmacology. XXIII. The angiotensin II receptors
12. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells
13. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
14. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor
15. Nonpeptide angiotensin II receptor antagonists
16. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats
17. Candesartan cilexetil: Safety and tolerability in healthy volunteers and patients with hypertension
18. Chymase as a proangiogenic factor
19. Do inhibitors of angitensin-I-converting enzyme protect against risk of cancer?
20. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522
21. Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model, a comparative study with captopril
22. Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice
23. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastic clones, is correlated with the immunogenic properties of the tumor cells
24. Intratumor microvessel density as a prognostic factor in cancer
25. Mouse glomerular epithelial cells in culture with features of podocytes in vivo express aminopeptidase A and angiotensinogen but not other components of the renin-angiotensin system
26. Role of Janus kinase/signal transducer and activator of transcription and mitogen- activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation
27. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells
28. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: Possible role of the vascular endothelial growth factor
29. The implications of angiogenesis for the biology and therapy of cancer metastasis
30. Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation
31. Analysis of experimental antiangiogenic therapy
32. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
33. Tumor angiogenesis: Past, presernt and the near future
34. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo